Synapsoft logo
AI Insights from Disclosures
Searching...
CHONGKUNDANG HOLDINGS CORP. 001630
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
CHONGKUNDANG HOLDINGS CORP. converted to a holding company structure on November 2, 2013 through a spin-off into CHONGKUNDANG HOLDINGS CORP. (the surviving entity), responsible for the investment business, and CHONG KUN DANG CORP. (the newly established entity), responsible for the pharmaceutical business. As the surviving entity of the split, the company holds all of the equity stakes in subsidiaries and affiliates that were held by the pre-split company, and is accordingly directly or indirectly affected by the industry environment and business performance of those subsidiaries and affiliates.
Representative Director Choi Huinam
Founded January 10, 1956
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 11011-0028955
Business number 113-81-06667
Phone Number 02-6373-0600
Fax Number 02-6373-0659
Company Address 8 Chungjeong-ro, Seodaemun-gu, Seoul

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant